NO20003065L - Kombinasjon for effektiv behandling av impotens - Google Patents

Kombinasjon for effektiv behandling av impotens

Info

Publication number
NO20003065L
NO20003065L NO20003065A NO20003065A NO20003065L NO 20003065 L NO20003065 L NO 20003065L NO 20003065 A NO20003065 A NO 20003065A NO 20003065 A NO20003065 A NO 20003065A NO 20003065 L NO20003065 L NO 20003065L
Authority
NO
Norway
Prior art keywords
impotence
combination
effective treatment
effective
treatment
Prior art date
Application number
NO20003065A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003065D0 (no
Inventor
Michael Grant Wyllie
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22090927&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003065(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20003065D0 publication Critical patent/NO20003065D0/no
Publication of NO20003065L publication Critical patent/NO20003065L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20003065A 1997-12-16 2000-06-15 Kombinasjon for effektiv behandling av impotens NO20003065L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6974197P 1997-12-16 1997-12-16
PCT/IB1998/001723 WO1999030697A2 (en) 1997-12-16 1998-10-29 Combination effective for the treatment of impotence

Publications (2)

Publication Number Publication Date
NO20003065D0 NO20003065D0 (no) 2000-06-15
NO20003065L true NO20003065L (no) 2000-08-15

Family

ID=22090927

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003065A NO20003065L (no) 1997-12-16 2000-06-15 Kombinasjon for effektiv behandling av impotens

Country Status (37)

Country Link
EP (1) EP1037616B1 (cs)
JP (2) JP2002508315A (cs)
KR (1) KR20010033092A (cs)
CN (1) CN1282248A (cs)
AP (1) AP915A (cs)
AR (1) AR016433A1 (cs)
AT (1) ATE318602T1 (cs)
AU (1) AU759825B2 (cs)
BG (1) BG104528A (cs)
BR (1) BR9813699A (cs)
CA (1) CA2314993A1 (cs)
CO (1) CO4810381A1 (cs)
CZ (1) CZ20002199A3 (cs)
DE (1) DE69833671T2 (cs)
DZ (1) DZ2675A1 (cs)
EA (1) EA200000526A1 (cs)
ES (1) ES2258300T3 (cs)
GT (1) GT199800177A (cs)
HN (1) HN1998000174A (cs)
HR (1) HRP20000407A2 (cs)
HU (1) HUP0100705A3 (cs)
IL (1) IL136515A0 (cs)
IS (1) IS5504A (cs)
MA (1) MA26586A1 (cs)
NO (1) NO20003065L (cs)
NZ (1) NZ504487A (cs)
OA (1) OA11423A (cs)
PA (1) PA8462801A1 (cs)
PE (1) PE20000011A1 (cs)
PL (1) PL341575A1 (cs)
SK (1) SK8782000A3 (cs)
TN (1) TNSN98227A1 (cs)
TR (1) TR200001733T2 (cs)
UY (1) UY25300A1 (cs)
WO (1) WO1999030697A2 (cs)
YU (1) YU33700A (cs)
ZA (1) ZA9811507B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
DE19844162A1 (de) * 1998-09-25 2000-03-30 Udo Dunzendorfer Medikamentenkombinationen zur Therapie der erektilen Dysfunktion
CA2362918A1 (en) * 1999-03-08 2000-09-14 Elizabeth Stoner Methods and compositions for treating erectile dysfunction
US7235625B2 (en) * 1999-06-29 2007-06-26 Palatin Technologies, Inc. Multiple agent therapy for sexual dysfunction
HK1044277B (en) * 1999-08-03 2014-02-28 Icos Corporation Pharmaceutical formulation comprising a beta-carboline and its use for treating sexual dysfunction
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
WO2002022127A1 (en) * 2000-09-13 2002-03-21 Isis Innovation Limited Use of phosphodiesterase inhibitors for the treatment of anorectal disorders
KR20030051843A (ko) * 2000-11-17 2003-06-25 워너-램버트 캄파니 엘엘씨 성기능 장애의 치료
US20030114469A1 (en) * 2001-09-27 2003-06-19 Cohen David Saul Combinations
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
GB0225908D0 (en) * 2002-11-06 2002-12-11 Pfizer Ltd Treatment of female sexual dysfunction
US7323462B2 (en) 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
US7291640B2 (en) 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
AP2007004047A0 (en) 2005-01-20 2007-06-30 Pfizer Ltd Substituted triazole derivatives as oxtocin antagonists
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
TWI435729B (zh) 2005-11-09 2014-05-01 Combinatorx Inc 治療病症之方法，組合物及套組
US8293489B2 (en) 2007-01-31 2012-10-23 Henkin Robert I Methods for detection of biological substances
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN101781302B (zh) * 2009-05-31 2013-07-10 段波 一种磷酸二酯酶抑制剂和异黄酮形成的加成物及其应用
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
US20150297601A1 (en) 2012-10-05 2015-10-22 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN106233141B (zh) 2014-02-18 2018-08-21 罗伯特·I·汉金 用于诊断和治疗味觉或嗅觉的损失和/或失真的方法和组合物
US11590209B2 (en) 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA878182B (en) * 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
DE69105040T2 (de) * 1990-05-31 1995-03-23 Pfizer, Inc., New York, N.Y. Arzneimittel gegen Impotenz.
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9523752D0 (en) * 1995-11-21 1996-01-24 Pfizer Ltd Pharmaceutical formulations

Also Published As

Publication number Publication date
NO20003065D0 (no) 2000-06-15
EP1037616B1 (en) 2006-03-01
SK8782000A3 (en) 2002-03-05
ZA9811507B (en) 2000-06-19
JP2007332156A (ja) 2007-12-27
EP1037616A2 (en) 2000-09-27
ATE318602T1 (de) 2006-03-15
BG104528A (en) 2001-02-28
CN1282248A (zh) 2001-01-31
HUP0100705A2 (hu) 2001-08-28
IS5504A (is) 2000-05-19
KR20010033092A (ko) 2001-04-25
UY25300A1 (es) 2000-12-29
NZ504487A (en) 2002-11-26
HUP0100705A3 (en) 2001-12-28
PA8462801A1 (es) 2000-05-24
DE69833671D1 (de) 2006-04-27
DE69833671T2 (de) 2006-11-30
MA26586A1 (fr) 2004-12-20
CZ20002199A3 (cs) 2001-10-17
CO4810381A1 (es) 1999-06-30
OA11423A (en) 2004-04-21
AU759825B2 (en) 2003-05-01
TNSN98227A1 (fr) 2005-03-15
AU9455898A (en) 1999-07-05
GT199800177A (es) 2000-05-02
AR016433A1 (es) 2001-07-04
DZ2675A1 (fr) 2003-03-29
AP915A (en) 2000-12-18
IL136515A0 (en) 2001-06-14
TR200001733T2 (tr) 2000-11-21
HRP20000407A2 (en) 2000-10-31
EA200000526A1 (ru) 2000-12-25
AP9801414A0 (en) 1998-12-31
WO1999030697A3 (en) 1999-08-26
BR9813699A (pt) 2000-10-10
PL341575A1 (en) 2001-04-23
WO1999030697A2 (en) 1999-06-24
ES2258300T3 (es) 2006-08-16
YU33700A (sh) 2004-05-12
PE20000011A1 (es) 2000-01-18
HN1998000174A (es) 1999-01-08
JP2002508315A (ja) 2002-03-19
CA2314993A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
NO20003065L (no) Kombinasjon for effektiv behandling av impotens
NO986052D0 (no) Antikonvulsive derivater for behandling av fedme
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
EP0996433A4 (en) Methods for treatment of conditions associated with lactosylceramide
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
IS4789A (is) Meðferðarefnasambönd
NO996545L (no) Behandling av aluminiumslagg
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
GB9723258D0 (en) Treatment of organic materials
NO982562D0 (no) Sammensetning for behandling av smerte
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
NO20006383D0 (no) Fremgangsmåte for behandling
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
FI971625A7 (fi) Teräksen lämpökäsittely
NO20000274D0 (no) Behandling av fluider
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID17459A (id) Unsur-unsur pengobatan
GB2324962B (en) Treatment of allergic conditions
NO942963D0 (no) Behandling av erektil dysfunksjon
ID29414A (id) Pengobatan depresi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application